Results 141 to 150 of about 44,405 (256)

Progressive Supranuclear Palsy Syndrome: An Overview

open access: yesIBRO Neuroscience Reports
Progressive supranuclear palsy (PSP) is a neurodegenerative disease, commonly observed as a movement disorder in the group of parkinsonian diseases. The term PSP usually refers to PSP-Richardson’s syndrome (PSP-RS), the most typical clinical presentation.
Eduardo Ichikawa-Escamilla   +2 more
doaj   +1 more source

Reversible drug-induced progressive supranuclear palsy-like presentation: A report of three cases

open access: yesAnnals of Movement Disorders, 2019
Drugs, such as dopamine receptor blockers or dopamine depleters, produce a functional dopamine-deficient state mimicking parkinsonism, but presentation with a progressive supranuclear palsy (PSP) is a rare manifestation.
Shivani Rath, Deepika Joshi
doaj   +1 more source

Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease [PDF]

open access: yes, 2005
beta-CIT binding in both caudate nuclei was lower than in the group of patients with IPD. In addition, putamen to caudate binding ratios were higher in the group of APS patients.
A Antonini   +39 more
core   +1 more source

Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.

open access: yesJAMA Neurology, 2019
Importance The association between the microtubule-associated protein tau (MAPT) H1 haplotype and the risk of progressive supranuclear palsy (PSP) has been well documented.
M. Heckman   +14 more
semanticscholar   +1 more source

Frontotemporal dementia: Clinical aspects, genetics, and neuropathology of a family with a C9ORF72 expansion in Argentina

open access: yesBrain Pathology, EarlyView.
Immunohistochemistry for TDP‐43: (A)—Dentate gyrus; (B)—Temporal lobe. Abstract Frontotemporal dementia (FTD) is the second most common cause of early‐onset dementia, typically manifesting before the age of 65, with a mean onset at 58 years. FTD may encompass a spectrum of neurodegenerative disorders resulting from frontotemporal lobar degeneration ...
Karen Daniela Román   +13 more
wiley   +1 more source

Adult lifespan normative data (18–92 years) for executive function tests; the Stroop colour word test, COWAT and Hayling sentence completion test

open access: yesJournal of Neuropsychology, EarlyView.
Abstract The neuropsychological assessment of executive functions is an important part of the diagnostic process for many neurological diseases and for predicting the ability of neurological patients to function independently. Unfortunately, for the majority of commonly used executive function tests there is a paucity of updated normative data ...
Patrick Murphy   +2 more
wiley   +1 more source

Research on progressive supranuclear palsy

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2011
DOI:10.3969/j.issn.1672-6731.2011.01 ...
Yiming LIU, Jiazhen LI
doaj  

The neuroanatomical and neurochemical basis of apathy and impulsivity in frontotemporal lobar degeneration. [PDF]

open access: yes, 2018
Apathy and impulsivity are common and often coexistent consequences of frontotemporal lobar degeneration (FTLD). They increase patient morbidity and carer distress, but remain under-estimated and poorly treated.
Lansdall, CJ, Passamonti, L, Rowe, JB
core   +1 more source

STELLA‐FTD: Examination of a behavior change intervention for frontotemporal dementia family care partners

open access: yesAlzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 2, Issue 1, March 2026.
Abstract INTRODUCTION Frontotemporal dementia (FTD) is the most common dementia in people under age 60. Although FTD is often characterized by behavioral symptoms, few national interventions address management of these symptoms. Here we describe our protocol for Support via Technology: Living and Learning with Advancing FTD (STELLA‐FTD), an ...
Allison Lindauer   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy